Skip to main content

Advertisement

Log in

Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background/aim

To assess sarcopenia and dynapenia and their relationship with disease severity and disabilities in PD and to state body composition in PD.

Methods

We conducted a case–control, cross-sectional study that included 70 patients with idiopathic PD and 85 controls. Sarcopenia was defined according to the European Working Group on Sarcopenia in Older People (EWGSOP) criteria. Dynapenia was detected by a handheld dynamometer. Bioimpedance analysis (BIA) was performed, and the SARC-F questionnaire was applied. Disabilities were appointed according to the Katz and Lawton indexes.

Results

Sarcopenia and dynapenia were more prevalent in PD than in controls (50 vs 30.6% and 31.4 vs 17.6%, respectively). Dynapenia was significantly associated with the severity of the disease and disabilities (p = 0.047, p = 0.001); however, sarcopenia was not. The skeletal muscle mass index (SMMI), fat mass index (FMI), and fat-free mass index (FFMI) did not differ between the PD and controls. FMI was lower in the advanced stages of the disease. Higher scores in the SARC-F questionnaire were significantly associated with disabilities and the severity of the disease (p < 0.001, p < 0.001).

Conclusion

Muscle strength was closely associated with the severity of the disease and disabilities in PD, but muscle mass was not. Sarcopenia, defined by the SARC-F questionnaire, was a good predictor of disabilities in PD, while the EWGSOP criteria were not. PD patients have a favorable body composition even in advanced stages of the disease with lower FMI and protected lean mass.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Shulman LM (2010) Understanding disability in Parkinson's disease. Mov Disord 25:131–135

    Article  Google Scholar 

  2. Lauretani F, Maggio M, Silvestrini C, Nardelli A, Saccavini M, Ceda GP (2012) Parkinson's disease (PD) in the elderly: an example of geriatric syndrome (GS)? Arch Gerontol Geriatr 54:242–246

    Article  Google Scholar 

  3. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010l) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423

    Article  Google Scholar 

  4. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R (2004) Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 159:413–421

    Article  Google Scholar 

  5. Lauretani F, Bautmans I, De Vita F et al (2014) Identification and treatment of older persons with sarcopenia. Aging Male 17:199–204

    Article  Google Scholar 

  6. Drey M, Hasmann SE, Krenovsky JP et al (2017) Associations between early markers of Parkinson's disease and sarcopenia. Front Aging Neurosci 9:53

    Article  Google Scholar 

  7. Barichella M, Pinelli G, Iorio L, Cassani E, Valentino A, Pusani C, Ferri V, Bolliri C, Pasqua M, Pezzoli G, Frazzitta G, Cereda E (2016) Sarcopenia and dynapenia in patients with parkinsonism. J Am Med Dir Assoc 17:640–646

    Article  Google Scholar 

  8. Vetrano DL, Pisciotta MS, Laudisio A, Lo Monaco MR, onder G, Brandi V, Fusco D, di Capua B, Ricciardi D, Bernabei R, Zuccalà G (2018) Sarcopenia in Parkinson disease: comparison of different criteria and association with disease severity. J Am Med Dir Assoc 19:523–527

    Article  Google Scholar 

  9. Yazar T, Yazar HO, Zayimoğlu E, Çankaya S (2018 Aug) Incidence of sarcopenia and dynapenia according to stage in patients with idiopathic Parkinson's disease. Neurol Sci 39(8):1415–1421

    Article  Google Scholar 

  10. Tan AH, Hew YC, Lim SY, Ramli NM, Kamaruzzaman SB, Tan MP, Grossmann M, Ang BH, Tan JY, Manap MAAA, Tay TK, Tan SL, New RP, Fadzli F, Yee EJ, Moy FM, Mahadeva S, Lang AE (2018) Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord 56:58–64

    Article  Google Scholar 

  11. Janssen I, Heymsfield SB, Baumgartner RN, Ross R (2000) Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 89:465–471

    Article  CAS  Google Scholar 

  12. Malmstrom TK, Morley JE (2013) SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14:531–532

    Article  Google Scholar 

  13. Bahat G, Yilmaz O, Kılıç C et al (2018) Performance of SARC-F in regard to sarcopenia definitions, muscle mass and functional measures. J Nutr Health Aging 22:898–903

    Article  CAS  Google Scholar 

  14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  Google Scholar 

  15. Bahat G, Tufan A, Tufan F, Kilic C, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ (2016) Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr 35:1557–1563

    Article  Google Scholar 

  16. Katz S, Akpom CA (1976) Index of ADL. Med Care 14:116–118

    Article  CAS  Google Scholar 

  17. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 9:179–186

    Article  CAS  Google Scholar 

  18. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427–442

    Article  CAS  Google Scholar 

  19. Cereda E, Cassani E, Barichella M, Spadafranca A, Caccialanza R, Bertoli S, Battezzati A, Pezzoli G (2012) Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 31:699–704

    Article  Google Scholar 

  20. van der Marck MA, Dicke HC, Uc EY, Kentin ZHA, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267

    Article  Google Scholar 

  21. Bernhardt D, Müller HP, Ludolph AC, Dupuis L, Kassubek J (2016) Body fat distribution in Parkinson's disease: an MRI-based body fat quantification study. Parkinsonism Relat Disord 33:84–89

    Article  Google Scholar 

  22. Wills AM, Pérez A, Wang J, Su X, Morgan J, Rajan SS, Leehey MA, Pontone GM, Chou KL, Umeh C, Mari Z, Boyd J, NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators (2016) Association between change in body mass index, unified Parkinson's disease rating scale scores, and survival among persons with Parkinson disease: secondary analysis of longitudinal data from NINDS exploratory trials in Parkinson disease long-term study 1. JAMA Neurol 73:321–328

    Article  Google Scholar 

  23. Beyer PL, Palarino MY, Michalek D et al (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983

    Article  CAS  Google Scholar 

  24. Warren Olanow C, Kieburtz K, Rascol O, Poewe W, Schapira AH, Emre M, Nissinen H, Leinonen M, Stocchi F, Stalevo Reduction in Dyskinesia Evaluation in Parkinson's Disease (STRIDE-PD) Investigators (2013) Factors predictive of the development of levodopa-induced dyskinesia and wearing-off in Parkinson's disease. Mov Disord 28:1064–1071

    Article  CAS  Google Scholar 

  25. Balogun S, Winzenberg T, Wills K, Scott D, Jones G, Aitken D, Callisaya ML (2017) Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults. J Nutr Health Aging 21:843–848

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Merve Çalışkan for taking anthropometric measurements of the patients.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Firuzan Fırat Ozer.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ozer, F.F., Akın, S., Gultekin, M. et al. Sarcopenia, dynapenia, and body composition in Parkinson’s disease: are they good predictors of disability?: a case–control study. Neurol Sci 41, 313–320 (2020). https://doi.org/10.1007/s10072-019-04073-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-019-04073-1

Keywords

Navigation